Aug. 12, 2021

Biotech to the Future

Listen as CSWMD's Dr. Diane DiEuliis and Austin Walne, Partner at ARTIS Ventures, speak to the Center for Strategic and International Studies (CSIS) Tech Unmanned podcast about emerging biotechnologies. The views expressed in the podcast are those of the individual and not the organization.

July 28, 2021

“Designer Biology” and the Need for Biosecurity-by-Design

CSWMD's Dr. Diane DiEuliis and Dr. James Giordano, Departments of Neurology and Biochemistry and Cyber-SMART Center, Georgetown University are featured in the latest issue of CBRNe Society's NCT Magazine.

March 11, 2021

Want to Grow the Economy? Try Fermenting It Instead

U.S. industry’s distribution system and supply chains were vulnerable before COVID, but pandemic-related disruptions to supply chains fully exposed this already alarming problem. U.S. manufacturers have relied too heavily on foreign materials for production, and the steady off-shoring of critical industries over a course of decades has reduced direct control of vital defense-related manufacturing should it be needed.

Dec. 9, 2020

The biosecurity benefits of genetic engineering attribution

In a recent volume of Nature Communications, Dr. Gerald Epstein and colleagues examine the biosecurity benefits of genetic engineering attribution. This paper is a policy companion piece to a technical paper, published in the same issue, announcing new results in using machine learning to recognize the source of a genetically engineered DNA.

Dec. 2, 2019

Synthetic Biology Industry Practices and Opportunities for Biosecurity and Potential Roles for the U.S. Government

This report summarizes discussions with industry representatives about the current and future structure of the synthetic biology industry, perspectives on potential misuse and vulnerabilities of synthetic biology tools and capabilities, and business practices to prevent misuse of tools and to protect industry assets.

Aug. 22, 2019

Biospecimens and the Information Landscape for Biodefense

As genomic sequencing and synthesis tools continue to grow, the genomic information associated with biospecimens is expanding rapidly; the convergence of the physical and digital worlds has yet unexamined impacts to our traditional biodefense frameworks.

July 9, 2018

The Digitization of Biology: Understanding the New Risks and Implications for Governance

In research paper no. 3, Dr. Natasha Bajema, Dr. Diane DiEuliis, Mr. Charles Lutes and Mr. Yong-Bee Lim explore the implications of the digitization of biology, identify new risks and challenges for governance.

April 4, 2018

Biodata Risks and Synthetic Biology: A Critical Juncture

Intrinsic to growing ability to apply classical engineering to biological systems is the mounting ‘digitization of biology’, as the genetic code and its related metadata (including translated proteins, associated functions, herein referred to as “biodata”) are amassed in order to engineer biology for specific purposes. There are three unique risks categories associated with the digitization of biology: 1) pathogen risks; 2) manufacturing risks, and 3) risks to individual privacy that can allow human harms.

Oct. 3, 2017

Options for Synthetic DNA Order Screening, Revisited

DNA synthesis is a valuable research tool in the design of new biological products for medicine and manufacturing, and the ability to chemically synthesize long tracts of DNA has allowed for the development of influenza vaccines and diagnostic tests.